Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma.Glembatumumab is a naked antibody to Glembatumumab vedotin and can be used to study antibody-acti
CAS Number:
[1020264-78-1]
* VAT and and shipping costs not included. Errors and price changes excepted